3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Sarcoma
2
Uterine Cervical Neoplasms
1
Skin Neoplasms
1
Neoplasm Metastasis
1
Leiomyosarcoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Cyclophosphamide
7
pembrolizumab
6
Radiosurgery
6
Specimen Handling
5
Nivolumab
5
Ifosfamide
5
fludarabine phosphate
4
Mycophenolic Acid
4
Granulocyte Colony-Stimulating Factor
4
Etoposide
4
Busulfan
4
Sunitinib
3
Sirolimus
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Melphalan
3
Magnetic Resonance Spectroscopy
3
Filgrastim
3
Cyclosporine
3
Cryosurgery
3
Carboplatin
3
trastuzumab deruxtecan
2
tislelizumab
2
sargramostim
2
pazopanib
2
fludarabine
2
etoposide phosphate
2
cabozantinib
2
Whole-Body Irradiation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Tissue Banks
×
Sarcoma
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled